BioVersys: Impactful Solutions for Antimicrobial Resistance (AMR)
We are thrilled to announce our upcoming webinar featuring Dr. Marc Gitzinger, CEO and Founder of BioVersys, as our guest speaker.
Dr. Gitzinger will share insights into combating antimicrobial resistance (AMR). The session will be moderated by Echo Hindle-Yang, CEO and Founder of MSQ Ventures.
Why Attend:
Explore BioVersys' innovative TRIC platform and BV-100 drug targeting highly resistant infections.
Learn about BioVersys' collaborations with global leaders like GSK and USC, driving breakthroughs with substantial support.
Addressing urgent needs with new antibiotics for resistant infections worldwide.
Insights on future antibiotic markets and policy changes shaping global health strategies
Date: July 17, 2024
Time: 9:00 PM BJT / 9:00 AM ET
About the Speaker:
Dr. Marc Gitzinger, Chief Executive Officer and co-founder of BioVersys with over 10 years of experience in the biotech industry, having launched a university spin-off in the field of antimicrobial resistance and growing it into a multi-asset clinical stage company. Some of these assets will address significant unmet medical needs in infectious conditions such as tuberculosis and hospital acquired Acinetobacter infections. Marc has raised over $70 mio in equity financing and secured over $30 mio in non-dilutive funding. He has also established several important partnerships with a Big Pharma and other development organizations. Multi-award-winning Biotech CEO, having received amongst others the Swiss Technology Award 2011, Venture Kick 2009 and Venture Leaders 2008 and 2017 awards for his work in founding and advancing BioVersys. He is also President of the Board of the BEAM Alliance, a European association representing over 70 European and international SMEs active in antimicrobial research and development and Board member of AMR Industry Alliance. Marc is a young thought leader in the field of antimicrobial research and development. He is passionate about next generation antimicrobial therapies and leads a highly motivated team striving to bring life-saving antimicrobial therapies to patients in need. He is also co-author on several high ranked scientific publications and patents in the field.
Can’t attend live? Register anyway, and we’ll send you the session recording after the event. Following the webinar, attendees will also have the chance to schedule a one-on-one session with BiOneCure through MSQ.